Intermittent High-Dose Scheduling of AZD8835, a Novel Selective Inhibitor of PI3Kα and PI3Kδ, Demonstrates Treatment Strategies for PIK3CA-Dependent Breast Cancers. (Q38797096)
Jump to navigation
Jump to search
scientific article published on 2 February 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intermittent High-Dose Scheduling of AZD8835, a Novel Selective Inhibitor of PI3Kα and PI3Kδ, Demonstrates Treatment Strategies for PIK3CA-Dependent Breast Cancers. |
scientific article published on 2 February 2016 |
Statements
Intermittent High-Dose Scheduling of AZD8835, a Novel Selective Inhibitor of PI3Kα and PI3Kδ, Demonstrates Treatment Strategies for PIK3CA-Dependent Breast Cancers (English)
Kevin Hudson
Urs J Hancox
Cath Trigwell
Robert McEwen
Urszula M Polanska
Myria Nikolaou
Pablo Morentin Gutierrez
Alvaro Avivar-Valderas
Oona Delpuech
Phillippa Dudley
Lyndsey Hanson
Alys Jones
Marie Cumberbatch
Sabina C Cosulich
Lara Ward
Francisco Cruzalegui